Jazz Pharmaceuticals plc Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax
Jazz Pharmaceuticals plc (JAZZ) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax · last filed 2026-08-03
- Jazz Pharmaceuticals plc other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Jazz Pharmaceuticals plc other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for the quarter ending 2026-03-31 was $0.00.
- Jazz Pharmaceuticals plc other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for the quarter ending 2025-12-31 was $25.00K, a 97.98% decline year-over-year.
- Jazz Pharmaceuticals plc other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for the quarter ending 2025-09-30 was $35.00K.
- Jazz Pharmaceuticals plc other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for fiscal 2025 was $65.00K, a 96.31% decline from fiscal 2024.
- Jazz Pharmaceuticals plc other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for fiscal 2024 was $1.76M, a 44.86% increase from fiscal 2023.
- Jazz Pharmaceuticals plc other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for fiscal 2023 was $1.22M.
- Jazz Pharmaceuticals plc other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, tax for fiscal 2022 was $0.00.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 3 month as first filed | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 6 month as first filed | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 9 month as first filed | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 12 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-03 | $0.00 10-Q · filed 2026-08-03 | $25.00K derived: sum of 3 quarters · filed 2026-08-03 | $60.00K derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-05 | $25.00K derived: sum of 2 quarters · filed 2026-05-05 | $60.00K derived: sum of 3 quarters · filed 2026-05-05 | $160.00K derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $60.00K derived: sum of 2 quarters · filed 2026-02-24 | $160.00K derived: sum of 3 quarters · filed 2026-08-03 | $65.00K 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $35.00K 10-Q · filed 2025-11-05 | $135.00K derived: sum of 2 quarters · filed 2026-08-03 | $40.00K 10-Q · filed 2025-11-05 | $1.27M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-06-30 | $100.00K 10-Q · filed 2026-08-03 | $142.00K 10-Q · filed 2025-08-06 | $0.00 10-Q · filed 2026-08-03 | $5.00K 10-Q · filed 2025-08-06 | $1.24M derived: sum of 3 quarters · filed 2026-08-03 | -$489.00K derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-03-31 | -$100.00K 10-Q · filed 2026-05-05 | -$147.00K 10-Q · filed 2025-05-07 | $1.14M derived: sum of 2 quarters · filed 2026-05-05 | -$589.00K derived: sum of 3 quarters · filed 2026-05-05 | -$60.00K derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$489.00K derived: sum of 2 quarters · filed 2026-02-24 | $40.00K derived: sum of 3 quarters · filed 2026-02-24 | $1.76M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | -$1.73M 10-Q · filed 2025-11-05 | -$1.20M derived: sum of 2 quarters · filed 2025-11-05 | $522.00K 10-Q · filed 2025-11-05 | -$1.33M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $529.00K 10-Q · filed 2025-08-06 | $2.25M 10-Q · filed 2025-08-06 | $401.00K derived: sum of 3 quarters · filed 2026-02-24 | $1.58M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $1.72M 10-Q · filed 2025-05-07 | -$128.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.05M derived: sum of 3 quarters · filed 2026-02-24 | $2.94M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | -$1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$672.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.22M derived: sum of 3 quarters · filed 2026-02-24 | $1.22M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $1.18M 10-Q · filed 2024-11-07 | $3.06M derived: sum of 2 quarters · filed 2024-11-07 | $3.06M 10-Q · filed 2024-11-07 | $3.06M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | $1.89M 10-Q · filed 2024-08-01 | $1.89M 10-Q · filed 2024-08-01 | $1.89M derived: sum of 3 quarters · filed 2025-02-26 | $1.89M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-02 | $0.00 derived: sum of 2 quarters · filed 2025-02-26 | $0.00 derived: sum of 3 quarters · filed 2025-02-26 | $0.00 derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $0.00 derived: sum of 2 quarters · filed 2025-02-26 | $0.00 derived: sum of 3 quarters · filed 2025-02-26 | $0.00 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | -$4.00K derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | -$4.00K derived: sum of 3 quarters · filed 2024-02-28 | -$4.00K derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-04 | -$4.00K derived: sum of 2 quarters · filed 2024-02-28 | -$4.00K derived: sum of 3 quarters · filed 2024-02-28 | -$3.00K derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$4.00K derived: sum of 2 quarters · filed 2024-02-28 | -$3.00K derived: sum of 3 quarters · filed 2024-02-28 | -$2.00K 10-K · filed 2024-02-28 | $353.00K 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $22.00K 10-Q · filed 2021-11-09 | $1.00K derived: sum of 2 quarters · filed 2022-11-09 | $2.00K 10-Q · filed 2022-11-09 | $353.00K 10-Q · filed 2021-11-09 | $811.00K derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | $1.00K 10-Q · filed 2022-08-03 | $168.00K 10-Q · filed 2021-08-03 | -$2.00K 10-Q · filed 2022-08-03 | $331.00K 10-Q · filed 2021-08-03 | $811.00K derived: sum of 3 quarters · filed 2023-03-01 | $978.00K derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | -$166.00K 10-Q · filed 2022-05-04 | $163.00K 10-Q · filed 2021-05-04 | $810.00K derived: sum of 2 quarters · filed 2023-03-01 | $977.00K derived: sum of 3 quarters · filed 2023-03-01 | $1.06M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2020-12-31 | $976.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.14M derived: sum of 2 quarters · filed 2023-03-01 | $1.23M derived: sum of 3 quarters · filed 2023-03-01 | $649.00K 10-K · filed 2023-03-01 | -$163.00K 10-K · filed 2021-02-23 | |||
| 2020-09-30 | $167.00K 10-Q · filed 2021-11-09 | $252.00K derived: sum of 2 quarters · filed 2021-11-09 | -$327.00K 10-Q · filed 2021-11-09 | -$255.00K derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $85.00K 10-Q · filed 2021-08-03 | -$494.00K 10-Q · filed 2021-08-03 | -$422.00K derived: sum of 3 quarters · filed 2022-03-01 | -$502.00K derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | -$579.00K 10-Q · filed 2021-05-04 | -$507.00K derived: sum of 2 quarters · filed 2022-03-01 | -$587.00K derived: sum of 3 quarters · filed 2022-03-01 | |||||
| 2019-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$8.00K derived: sum of 2 quarters · filed 2022-03-01 | -$697.00K 10-K · filed 2022-03-01 | |||||
| 2019-09-30 | -$80.00K 10-Q · filed 2020-11-02 | -$769.00K 10-Q · filed 2020-11-02 | ||||||
| 2018-12-31 | $289.00K 10-K · filed 2021-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |